News and Comments

SAREPTA: What's Going On ?

  Tuesday, April 16, 2013

The requests Sarepta Therapeutics (SRPT) has gotten from the FDA represent a sign of FDA seriousness towards bringing the firm’s drug eteplirsen for Duchenne muscular dystrophy as soon as possible to the children suffering from the debilitating, fast deteriorating disease. The FDA did not wait for the firm to file for early approval, it rather asked Sarepta to bring in more data that would legitimize granting early approval of the first drug ever to claim treating the disabling disease at its root-origin. Investors who should have been optimistic about the FDA initiative sold their shares instead, causing them to lose around 10% of their value.  More...

ImmunoGen Offers New Hopes For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Difficult-To-Treat Cancers

  Friday, April 12, 2013

 More...

A Quick Response To ARIAD'S (ARIA) Conference Call

  Thursday, April 04, 2013

 More...


Recent Postings


Archive


Tags

GlaxoSmithKline (GSK) ACADIA (ACAD) Merck (MRK) Prosensa (RNA) PTC Therapeutics (PTCT) Rapamune Sanofi (SNA) IDERA (IDRA) CompuGen (CGEN) Xoma (XOMA) Intrexon (XON) Anacor (ANAC) SYNTA (SNTA) RenenxBio (RGNX) NEKTAR (NKTR)) Galena (GALE) Dynavax (DVAX) Alder Biopharmaceuticals (ALDR) Theravance (THRX) Intercept (ICPT) Regeneron (REGN) GUARDIAN HEALTH Genentech Jazz Pharmaceuticals (JAZZ) ImmunoGen (IMGN) NANTKWEST (NK) ARCA (ABIO) INNOVIVA (INVA) Agenus (AGEN AERIE PHARMACEUTICALS KITE (KITE) Micromet (MITI) SUNESIS PHARMACEUTICALS (SNSS) Revlimid (lenolidamide) Sangamo (SGMO) TOKAI (TKAOI) Pluristem (PSTI) ARGOS (ARGS) OSI (OSIP) Human Longevity (HLI) HALOZYME (HALO) Ridaforolimus Tysabri Seattle Genetics (SGEN) Elan (ELN) Abbott Laboratories (ABT) Auspex (ASPX) Illumina (ILMN) Gilead (GILD) Telaprevir Multiple Myeloma galapagos (GLPG) BIOMARIN (BMRN) Anadys (ANDS) Benlysta (belimumab) Ziofpharm (ZIOP) C4 Therapeutics Array Pharmaceuticals (ARRY) AGOS (ARGS) Endometrial Cancer Inovio (INO) Global Cell Therapeutics (GBT) Bristol-Myers Squibb (BMY) JUNO (JUNO) Trastuzumab-DM1 Valeant Pharmaceuticals International (VRX) ADVENTRIX (ANX) Zerenex ISIS (ISIS) Amgen (AMGN) Vertex (VRTX) Sequenom (SQNM) Sarepta (SRPT) Herceptin Alnylam (ALNY) ZALTRAP™ Dendreon (DNDN) Onyx (ONXX) Roche (ROCHE) SERES THERAPEUTICS (MCRB) Vitae Pharmaceuticals (VTAE) Ionis (IONS) Aimmune Therapeutics (AIMT) VANDA (VNDA) Intermune (ITMN) ABBVIE (ABBV) Sanofi (SNY) Theravance Bio Pharma (TBPH) Idenix (IDIX) Biocryst (BCRX) Incyte (INCY) Velcade (bortezomib) KERYX (KERX) Roche (RHHBY) Mirati Therapeutics (MRTX) Prolor Biotech (PBTH) Biogen Idec (BIIB) Agenus (AGEN) Ariad (ARIA) Cytokinetics (CYTK) Spike Therapeutics (ONCE) REGULUS (RGLS) Sanofi-Aventis (SAN) Editas (EDIT) Exelixis (EXEL) Human Genome Sciences (HGSI)